DUAL ANTIGEN TARGETING WITH CO-TRANSDUCED CD19/22 CAR T CELLS MAY PREVENT ANTIGEN-NEGATIVE RELAPSE AFTER CAR T CELL THERAPY FOR RELAPSED/REFRACTORY ALL

被引：0

作者：

Lucchini, Giovanna ^{[1
]}

Ghorashian, Sara ^{[1
]}

Richardson, Rachel ^{[2
]}

Nguyen, Kyvi ^{[2
]}

Terris, Craig ^{[2
]}

Espuelas, Macarena Oporto ^{[2
]}

Yeung, Jenny

Chu, Jan ^{[1
]}

Williams, Lindsey ^{[1
]}

Ko, Kaye ^{[1
]}

Walding, Chloe ^{[3
]}

Watts, Kelly ^{[4
]}

Inglott, Sarah ^{[1
]}

Adams, Stuart ^{[1
]}

Gravett, Emma ^{[1
]}

Gilmour, Kimberly ^{[1
]}

Lal, Alka ^{[5
]}

Kunaseelan, Sangeetha ^{[5
]}

Popova, Bilyana ^{[5
]}

Lopes, Andre ^{[5
]}

Ngai, Yenting ^{[5
]}

Kokalaki, Eva ^{[6
]}

Carulla, Milena Balasch ^{[1
]}

Mullanfiroze, Khushnuma ^{[1
]}

Lazareva, Arina ^{[1
]}

Chiesa, Robert ^{[1
]}

Silva, Juliana ^{[1
]}

Rao, Kanchan ^{[1
]}

Bonney, Denise ^{[4
]}

Wynn, Robert ^{[4
]}

Pule, Martin ^{[6
]}

Hough, Rachael ^{[3
]}

Amrolia, Persis ^{[1
]}

机构：

[1] Great Ormond St Hosp NHS Fdn Trust, London, England

[2] UCL Great Ormond St Inst Child Hlth, London, England

[3] Univ Coll London Hosp NHS Trust, London, England

[4] Royal Manchester Childrens Hosp, Manchester, Lancs, England

[5] Canc Res UK & UCL Canc Trials Ctr, London, England

[6] Autolus Ltd, London, England

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O036

引用

页码：42 / 42

页数：1

共 50 条

[31] Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Hanren Dai
Zhiqiang Wu
Hejin Jia
Chuan Tong
Yelei Guo
Dongdong Ti
Xiao Han
Yang Liu
Wenying Zhang
Chunmeng Wang
Yajing Zhang
Meixia Chen
Qingming Yang
Yao Wang
Weidong Han
Journal of Hematology & Oncology, 13
[32] Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
不详
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : 45 - 51
[33] Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In Vivo
Annesley, Colleen
Gardner, Rebecca
Wilson, Ashley
Summers, Corinne
Lamble, Adam J.
Rivers, Julie
Wu, Qian Vicky
Brand, Adam
Johnson, Adam
Spratt, Karen
Mgebroff, Stephanie
Brown, Christopher
Lindgren, Catherine
Park, Julie R.
Jensen, Michael C.
BLOOD, 2019, 134
[34] Combating antigen escape with CD19/CD20 bispecific CAR-T cell therapy
Zah, Eugenia
Lin, Meng-Yin
Jensen, Michael C.
Silva-Benedict, Anne
Chen, Yvonne Y.
CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
[35] CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases
Cingireddy, Ananya Reddy
Flores, Brianna
Wuthrich, John
Cingireddy, Anirudh Reddy
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
[36] Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss
Bukhari, Ali
El Chaer, Firas
Koka, Rima
Singh, Zeba
Hutnick, Elizabeth
Ruehle, Kathleen
Lee, Seung Tae
Kocoglu, Mehmet H.
Shanholtz, Carl
Badros, Ashraf
Hardy, Nancy
Yared, Jean
Rapoport, Aaron P.
Dahiya, Saurabh
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : E273 - E275
[37] Preventing relapse after CD19 CAR T-cell ther apy for pedi at ric ALL: the role of trans plant and enhanced CAR T cells
Talleur, Aimee C.
Naik, Swati
Gottschalk, Stephen
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 91 - 96
[38] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Spiegel, Jay Y.
Patel, Shabnum
Muffly, Lori
Hossain, Nasheed M.
Oak, Jean
Baird, John H.
Frank, Matthew J.
Shiraz, Parveen
Sahaf, Bita
Craig, Juliana
Iglesias, Maria
Younes, Sheren
Natkunam, Yasodha
Ozawa, Michael G.
Yang, Eric
Tamaresis, John
Chinnasamy, Harshini
Ehlinger, Zach
Reynolds, Warren
Lynn, Rachel
Rotiroti, Maria Caterina
Gkitsas, Nikolaos
Arai, Sally
Johnston, Laura
Lowsky, Robert
Majzner, Robbie G.
Meyer, Everett
Negrin, Robert S.
Rezvani, Andrew R.
Sidana, Surbhi
Shizuru, Judith
Weng, Wen-Kai
Mullins, Chelsea
Jacob, Allison
Kirsch, Ilan
Bazzano, Magali
Zhou, Jing
Mackay, Sean
Bornheimer, Scott J.
Schultz, Liora
Ramakrishna, Sneha
Davis, Kara L.
Kong, Katherine A.
Shah, Nirali N.
Qin, Haiying
Fry, Terry
Feldman, Steven
Mackall, Crystal L.
Miklos, David B.
NATURE MEDICINE, 2021, 27 (08) : 1419 - +
[39] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y. Spiegel
Shabnum Patel
Lori Muffly
Nasheed M. Hossain
Jean Oak
John H. Baird
Matthew J. Frank
Parveen Shiraz
Bita Sahaf
Juliana Craig
Maria Iglesias
Sheren Younes
Yasodha Natkunam
Michael G. Ozawa
Eric Yang
John Tamaresis
Harshini Chinnasamy
Zach Ehlinger
Warren Reynolds
Rachel Lynn
Maria Caterina Rotiroti
Nikolaos Gkitsas
Sally Arai
Laura Johnston
Robert Lowsky
Robbie G. Majzner
Everett Meyer
Robert S. Negrin
Andrew R. Rezvani
Surbhi Sidana
Judith Shizuru
Wen-Kai Weng
Chelsea Mullins
Allison Jacob
Ilan Kirsch
Magali Bazzano
Jing Zhou
Sean Mackay
Scott J. Bornheimer
Liora Schultz
Sneha Ramakrishna
Kara L. Davis
Katherine A. Kong
Nirali N. Shah
Haiying Qin
Terry Fry
Steven Feldman
Crystal L. Mackall
David B. Miklos
Nature Medicine, 2021, 27 : 1419 - 1431
[40] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
Zhu, Haibo
Deng, Haobin
Mu, Juan
Lyu, Cuicui
Jiang, Yanyu
Deng, Qi
ONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037

← 1 2 3 4 5 →